Navigation Links
Cepheid Announces European Release of Xpert TV, a Next-Generation Molecular Test for Rapid and Accurate Identification of Trichomonas vaginalis Infections
Date:9/3/2014

SUNNYVALE, Calif., Sept. 3, 2014 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced the release of Xpert® TV, an on-demand molecular test for rapid, accurate and reproducible identification of Trichomoniasis (TV) infections in both males and females. The test will be marketed as a CE-IVD product under the European Directive on In Vitro Diagnostic Medical Devices, bringing the total number of CE-IVD tests available to nineteen. Xpert TV runs on Cepheid's GeneXpert® System, the world's leading molecular diagnostic platform with more than 7,000 systems installed worldwide.

Trichomoniasis, the most common nonviral sexually transmitted disease, is caused by infection with the protozoan parasite Trichomonas vaginalis. The World Health organization has estimated that 160 million cases of infection are acquired worldwide each year.1 Most people who have the parasite cannot tell they are infected, only about 30% develop any symptoms.

"Xpert TV is the first nucleic acid amplification test to deliver TV results for male urine samples. It has been difficult to identify and contain TV infections in men because traditional diagnostic methods are much less sensitive than real-time PCR," said John Bishop, Cepheid's Chairman and Chief Executive Officer. "Cepheid delivers the industry's most complete line of on-demand sexual health tests on a single molecular platform, enabling clinicians to deliver same day onsite patient consultation and treatment."

Identification of Trichomonas vaginalis infections is problematic. Organism viability, sensitivity issues with wet mount microscopy, and time delays for conclusive diagnosis from culture methods make detection of this asymptomatic infection a challenge. Xpert TV is a next generation solution. Each test cartridge includes three controls to ensure test integrity and performance. Samp
'/>"/>

SOURCE Cepheid
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cepheid to Webcast Upcoming Financial Presentations
2. Cepheid Announces Executive Vice President Emerging Markets
3. Cepheid Reports Fourth Quarter And Full Year 2012 Results
4. Cepheid Schedules 2013 First Quarter Results Announcement And Webcast
5. Cepheid and American Lung Association Partner for Tuberculosis Awareness in U.S.
6. Cepheid Receives FDA Market Authorization for Xpert MTB/RIF
7. Cepheid Launches Mobile Community for Ride Against TB Campaign to Benefit the American Lung Association
8. Cepheid Highlights Promising Early Performance Of Its Cervical Cancer Test At AMP
9. Cepheid to Webcast Upcoming Financial Presentation
10. New Products, Price Movements, and Leadership Appointments - Research Report on Waters, Cognex, Fluidigm, Cepheid, and Bio-Rad
11. Cepheid Reports 2014 Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014  RESMED INC. (NYSE: ... quarter of fiscal year 2015 results on Thursday, January 22, ... press release with ResMed,s results will be issued after 1:00 ... webcast to discuss operating results and future outlook. ... US Pacific Time and the live webcast of the call ...
(Date:12/19/2014)... and LYON, France , ... LLY ) and Adocia (Euronext Paris: FR0011184241 ... on developing an ultra-rapid insulin, known as BioChaperone Lispro, ... 2 diabetes. BioChaperone Lispro relies on Adocia,s proprietary BioChaperone® ... Lilly and Adocia will develop BioChaperone Lispro with ...
(Date:12/17/2014)... Revenue and earnings above the previous year - ... In the past 2013/14 fiscal year (ended 30 September ... 4.287 billion (last year: EUR 4.190 billion) despite unfavorable currency ... million. "Overall, 2013/14 was a successful fiscal year for the ... CEO of Carl Zeiss AG. "Thanks to our broad portfolio ...
Breaking Medicine Technology:ResMed To Announce Second Quarter 2015 Results 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3ZEISS Asserts its Position in Difficult Environment 2
... Wako Diagnostics, a division of Wako Chemicals USA, has ... Administration (FDA) to market the uTASWako i30 instrument with ... vitro diagnostic (IVD) tests in the USA.  The ... healthcare professionals as an aid in the risk assessment ...
... 2011 Developed by inventor John Vito and represented by ... lot disclose an advanced medical inhaler design that is both more ...   http://photos.prnewswire.com/prnh/20100614/CG20517LOGO ) The patents will be auctioned ... on March 31, 2011 in New York City. ...
Cached Medicine Technology:Announcing 510(k) Clearance of a New Microfluidic-based IVD Test System, the uTASWako® i30 Immunoanalyzer, and AFP-L3 and DCP Assays for Liver Cancer Risk Assessment. 2An Easier Way to Breathe Better - ICAP Ocean Tomo Announces an Advanced Medical Inhaler Design 2
(Date:12/19/2014)... (PRWEB) December 20, 2014 These vanadium ... and other nations. Around 151,000 tons of vanadium were ... The global vanadium usage increased at 6.7% AAGR during ... steel and iron industry, being the largest consumer, accounted ... 2013, followed by titanium-vanadium alloy and the chemical industry. ...
(Date:12/19/2014)... 2014 (HealthDay News) -- New research warns parents that buying an ... risk. Nearly half of teen drivers killed in the United ... least 11 years old and often lacked important safety features that ... of teen drivers killed in crashes were in cars at least ... years old, 31 percent were in cars 11 to 15 years ...
(Date:12/19/2014)... (HealthDay News) -- Injectable drug users who also use ... rate of other substance users, a new study finds. ... the risk of suicide attempt and completed suicide," Didier ... said in a university news release. "However, there are ... know who among substance users were actually more likely ...
(Date:12/19/2014)... Surviving Mesothelioma says thousands of water pipes in ... pipes can leach asbestos into drinking water as they age. ... on the Surviving Mesothelioma website. , According to the ... decaying water mains made of asbestos cement are the major ... protect consumers from mesothelioma , water providers are subject to ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 B. E. ... to healthcare providers, has been retained to lead a ... Memorial Hospital in Franklin, Ind. The top executive search ... recently placed more than 900 healthcare executives into organizations. ... full service hospital providing care to the residents of ...
Breaking Medicine News(10 mins):Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 2Health News:Marketresearchreports.biz: Global Vanadium Usage Increased at AAGR of 6.7% between 2001 and 2013 3Health News:Older Cars a Bad Choice for Younger Drivers 2Health News:Cocaine, Amphetamines May Up Injection Drug Users' Suicide Risk 2Health News:Surviving Mesothelioma Warns of Potential Mesothelioma Risk from Cement Water Pipes 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 3
... Researchers say cases go up in the warm-weather months when ... Air pollution is already linked to respiratory and cardiovascular ills, ... also cause appendicitis. , Authors of a new study published ... Association Journal found that cases of appendicitis go up ...
... to a clinical study released in The American Journal ... Pomegranate Juice may decrease the progression of arterial plaque in ... was intended to see if POM Wonderful 100% Pomegranate Juice ... artery (CIMT) in patients with moderate coronary heart disease risk. ...
... This year you can wear your Halloween costume twice while ... turn out in their favorite super hero costumes to raise ... Super Jake & Friends Heroes Bash on Saturday, ... benefit The Super Jake Foundation. , "The five-year ...
... China, Oct. 5 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc.,(Nasdaq: ... firm,specializing in the manufacture, research, development, marketing and,distribution ... its,previously announced underwritten public offering. The Company sold ... share in its public offering,resulting in approximately $65.5 ...
... Oct. 5 Everybody feels stressed at some point in their ... day: deadline pressures at work, financial concerns when a 401 (k) ... sick child, aging parents, and money woes -- just to name ... , It,s very easy to get stressed out over ...
... the patients who die in intensive care units die within ... good end-of-life care. Most relatives are nevertheless happy with the ... the University of Gothenburg, Sweden. An intensive care unit ... end-of-life care. When a patient dies on an ICU, this ...
Cached Medicine News:Health News:Air Pollution May Cause Appendicitis: Study 2Health News:Air Pollution May Cause Appendicitis: Study 3Health News:8 Ounces a Day of POM Wonderful 100% Pomegranate Juice May Slow Progression of Carotid Intima-Media Thickness (CIMT) in Patients with Elevated Cardiovascular Disease Risk Factors, Study Finds 2Health News:8 Ounces a Day of POM Wonderful 100% Pomegranate Juice May Slow Progression of Carotid Intima-Media Thickness (CIMT) in Patients with Elevated Cardiovascular Disease Risk Factors, Study Finds 3Health News:Super Jake Foundation Hosts 5th Annual Heroes Bash on Nov. 14 to Benefit Pediatric Cancer Research 2Health News:China-Biotics, Inc. Announces Closing of Public Offering of Common Stock 2Health News:China-Biotics, Inc. Announces Closing of Public Offering of Common Stock 3Health News:VIDEO from Medialink and CIGNA: Don't Stress Out Over Stress, Some of it is Good for You 2Health News:Intensive care units poorly equipped to care for the dying 2
For the direct quantitative determination of low density lipoprotein cholesterol (LDL-C) in human serum or plasma. For in vitro diagnostic use only....
For the quantitative determination of uric acid in serum....
The assay kit is for determination of uric acid in serum or urine. Wavelength: 600 nm. Linear range: up to 80 mg/dL....
For the quantitative determination of Uric Acid in serum. Linearity: 25 mg/dl....
Medicine Products: